News summary

Automation of Screening Studies for Compounds that Slow Aging is Becoming More Ambitious

Source: Fight Aging! • Published: 09 Sept 2026, 10:11

Summarized by Masters of Longevity from Fight Aging!.

Reports on a new integrated, high-throughput platform that automates longevity screening across yeast, worms, flies, killifish, and mice using imaging and machine learning.

Automation of Screening Studies for Compounds that Slow Aging is Becoming More Ambitious
Key Takeaways
  • The platform screened over 400 compounds across five species using miniaturized assays and longitudinal imaging.
  • Only a subset of compounds produced consistent lifespan extension across species, showing conserved geroprotectors are rare.
  • Several compounds including baicalein, doxycycline, forskolin, metformin, resveratrol, and rifampicin showed positive effects in multiple species.
Read the full article at Fight Aging!

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.